REVIEW
|
doi:10.20944/preprints202306.0956.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
NSCLC,; Immunotherapy; Immune Checkpoint Inhibitors; Special populations
Online: 13 June 2023 (16:01:04 CEST)
ARTICLE
|
doi:10.20944/preprints202404.1044.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Pembrolizumab; Non-small cell lung cancer; real-world data; Immunotherapy; observational study
Online: 16 April 2024 (14:06:32 CEST)